Campto

Campto (Irinotecan Hydrochloride Trihydrate) is an intravenous medication used in cancer treatment. This Pfizer-manufactured drug is designed to target and inhibit cancer cell growth, offering a critical option for certain oncology protocols.

Campto is primarily used in the treatment of metastatic colorectal cancer. It works by interfering with the enzymes needed for cancer cell replication, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Campto used for?'—it is typically prescribed for advanced stages of cancer where other treatments may have limited effectiveness.

Common effects of Campto may include nausea, vomiting, and diarrhea. Some patients also experience fatigue and hair loss. These effects can vary widely depending on individual health factors and the specific treatment protocol.

Campto should be handled with care, as it is a potent medication. It is essential to follow healthcare provider instructions closely. Patients should be monitored for severe side effects and report any unusual symptoms promptly. Proper storage and administration are crucial to ensure safety.

Campto may interact with other medications, including those that affect liver enzymes. Alcohol and certain supplements can also influence its effectiveness. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.